Maria Luisa Biondi

Circa Diatech Pharmacogenetics

Questo autore non ha riempito alcun dettaglio.
Finora Diatech Pharmacogenetics ha creato 1081 post nel blog.

12 06, 2020

La Diatech al TG3 Marche per parlare del nostro test COVID

Diatech Pharmacogenetics2020-06-12T15:39:55+02:00

8 06, 2020

Claudia Rengucci et. al., Evaluation of Colorectal Cancer Risk and Prevalence by Stool DNA Integrity Detection

Diatech Pharmacogenetics2020-11-03T14:51:18+01:00

3 06, 2020

EasyPGX the first RT-NGS system

Diatech Pharmacogenetics2020-06-04T12:52:38+02:00

2 06, 2020

Diatech Si Riconverte E Produce I Reagenti Per I Tamponi Covid-19 Ancora Scarsi Sul Mercato

Diatech Pharmacogenetics2020-06-08T12:38:26+02:00

2 06, 2020

Diatech Si Riconverte E Produce I Reagenti Per I Tamponi Covid-19 Ancora Scarsi Sul Mercato

Diatech Pharmacogenetics2020-06-08T12:29:58+02:00

1 06, 2020

Coronavirus, In Un Mese 250mila Kit Diagnostici Azienda Jesi – Marche

Diatech Pharmacogenetics2020-06-08T12:35:13+02:00

25 05, 2020

Alberto Pavan et. al., Plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC) patients (pts) treated with immune checkpoint inhibitors (ICIs): Impact of STK11 and TP53 mutations on outcome.

Diatech Pharmacogenetics2020-11-03T15:06:19+01:00

16 05, 2020

Alessandro Parisi et. al., Evaluation of Second-Line Anti-VEGF after First-Line Anti-EGFR Based Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Multicenter “SLAVE” Study

Diatech Pharmacogenetics2020-11-03T15:11:21+01:00

15 05, 2020

Ilaria Proietti et. al., A rare BRAF V600E mutation detected by next-generation sequencing in a superficial spreading melanoma: case report and potential diagnostic implications

Diatech Pharmacogenetics2020-11-03T15:59:46+01:00

7 05, 2020

Elisabetta Zulato et. al., Early assessment of KRAS mutation in cfDNA correlates with risk of progression and death in advanced non-small-cell lung cancer

Diatech Pharmacogenetics2020-11-03T15:24:44+01:00

Precedente 91011 Successivo